Page last updated: 2024-08-24

bromfenac and Retinal Vein Occlusion

bromfenac has been researched along with Retinal Vein Occlusion in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Shimura, M; Yasuda, K	1

Other Studies

1 other study(ies) available for bromfenac and Retinal Vein Occlusion

Article	Year
Topical bromfenac reduces the frequency of intravitreal bevacizumab in patients with branch retinal vein occlusion. The British journal of ophthalmology, 2015, Volume: 99, Issue:2 Topics: Administration, Topical; Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Benzophenones; Bevacizumab; Bromobenzenes; Case-Control Studies; Female; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Retinal Vein Occlusion; Retreatment; Vascular Endothelial Growth Factor A; Visual Acuity; Visual Fields	2015

Article

Year

Topical bromfenac reduces the frequency of intravitreal bevacizumab in patients with branch retinal vein occlusion.

The British journal of ophthalmology, 2015, Volume: 99, Issue:2

Topics: Administration, Topical; Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Benzophenones; Bevacizumab; Bromobenzenes; Case-Control Studies; Female; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Retinal Vein Occlusion; Retreatment; Vascular Endothelial Growth Factor A; Visual Acuity; Visual Fields

2015